72 related articles for article (PubMed ID: 26148174)
1. Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemia.
Tang G; Fu B; Hu S; Lu X; Tang Z; Li S; Jabbar K; Khoury JD; Medeiros LJ; Wang SA
Am J Hematol; 2015 Oct; 90(10):882-7. PubMed ID: 26148174
[TBL] [Abstract][Full Text] [Related]
2. Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.
Fabarius A; Kalmanti L; Dietz CT; Lauseker M; Rinaldetti S; Haferlach C; Göhring G; Schlegelberger B; Jotterand M; Hanfstein B; Seifarth W; Hänel M; Köhne CH; Lindemann HW; Berdel WE; Staib P; Müller MC; Proetel U; Balleisen L; Goebeler ME; Dengler J; Falge C; Kanz L; Burchert A; Kneba M; Stegelmann F; Pfreundschuh M; Waller CF; Spiekermann K; Brümmendorf TH; Edinger M; Hofmann WK; Pfirrmann M; Hasford J; Krause S; Hochhaus A; Saußele S; Hehlmann R;
Ann Hematol; 2015 Dec; 94(12):2015-24. PubMed ID: 26385387
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution.
Tang G; Zhang L; Fu B; Hu J; Lu X; Hu S; Patel A; Goswami M; Khoury JD; Garcia-Manero G; Medeiros LJ; Wang SA
Am J Hematol; 2014 Aug; 89(8):813-8. PubMed ID: 24782398
[TBL] [Abstract][Full Text] [Related]
5. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
Palomo L; Garcia O; Arnan M; Xicoy B; Fuster F; Cabezón M; Coll R; Ademà V; Grau J; Jiménez MJ; Pomares H; Marcé S; Mallo M; Millá F; Alonso E; Sureda A; Gallardo D; Feliu E; Ribera JM; Solé F; Zamora L
Oncotarget; 2016 Aug; 7(35):57021-57035. PubMed ID: 27486981
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 20q deletion: a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remission.
Sun J; Yin CC; Cui W; Chen SS; Medeiros LJ; Lu G
Am J Clin Pathol; 2011 Mar; 135(3):391-7. PubMed ID: 21350093
[TBL] [Abstract][Full Text] [Related]
7. Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases.
Palomo L; Xicoy B; Garcia O; Mallo M; Ademà V; Cabezón M; Arnan M; Pomares H; José Larrayoz M; José Calasanz M; Maciejewski JP; Huang D; Shih LY; Ogawa S; Cervera J; Such E; Coll R; Grau J; Solé F; Zamora L
Am J Hematol; 2016 Feb; 91(2):185-92. PubMed ID: 26509444
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.
Farag SS; Ruppert AS; Mrózek K; Carroll AJ; Pettenati MJ; Le Beau MM; Peterson BL; Powell BL; Ozer H; Silver RT; Larson RA; Bloomfield CD;
Int J Oncol; 2004 Jul; 25(1):143-51. PubMed ID: 15201999
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.
Wang W; Cortes JE; Tang G; Khoury JD; Wang S; Bueso-Ramos CE; DiGiuseppe JA; Chen Z; Kantarjian HM; Medeiros LJ; Hu S
Blood; 2016 Jun; 127(22):2742-50. PubMed ID: 27006386
[TBL] [Abstract][Full Text] [Related]
10. Impact of Additional Cytogenetic Abnormalities on the Clinical Behavior of Patients With Chronic Myeloid Leukemia: Report on a Latin American Population.
Morales-Chacón K; Bourlon C; Acosta-Medina AA; Bourlon MT; Aguayo A; Tuna-Aguilar E
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e299-e306. PubMed ID: 30905538
[TBL] [Abstract][Full Text] [Related]
11. Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia.
Sureda A; Carrasco M; de Miguel M; Martínez JA; Conde E; Sanz MA; Díaz-Mediavilla J; Sierra J
Haematologica; 2003 Nov; 88(11):1213-20. PubMed ID: 14607749
[TBL] [Abstract][Full Text] [Related]
12. [Study on prognostic significances of different cytogenetic risk categories in patients with primary myelodysplastic syndromes].
Qu SQ; Liu XP; Xu ZF; Zhang Y; Qin TJ; Zhang TJ; Cui R; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):819-24. PubMed ID: 22339954
[TBL] [Abstract][Full Text] [Related]
13. Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed AML.
Shimizu H; Yokohama A; Ishizaki T; Hatsumi N; Takada S; Saitoh T; Sakura T; Nojima Y; Handa H
Hematol Oncol; 2018 Feb; 36(1):252-257. PubMed ID: 28378367
[TBL] [Abstract][Full Text] [Related]
14. Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML.
Patnaik MM; Vallapureddy R; Yalniz FF; Hanson CA; Ketterling RP; Lasho TL; Finke C; Al-Kali A; Gangat N; Tefferi A
Am J Hematol; 2018 Jan; 93(1):65-73. PubMed ID: 29023992
[TBL] [Abstract][Full Text] [Related]
15. Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories.
Loghavi S; Sui D; Wei P; Garcia-Manero G; Pierce S; Routbort MJ; Jabbour EJ; Pemmaraju N; Kanagal-Shamanna R; Gur HD; Hu S; Zuo Z; Medeiros LJ; Kantarjian HM; Khoury JD
Blood Adv; 2018 Aug; 2(15):1807-1816. PubMed ID: 30054307
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia.
Groves MJ; Sales M; Baker L; Griffiths M; Pratt N; Tauro S
Cancer Genet; 2011 Jan; 204(1):39-44. PubMed ID: 21356190
[TBL] [Abstract][Full Text] [Related]
17. Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients.
Meggyesi N; Kozma A; Halm G; Nahajevszky S; Bátai A; Fekete S; Barta A; Ujj G; Lueff S; Sipos A; Adám E; Bors A; Reményi P; Masszi T; Tordai A; Andrikovics H
Acta Haematol; 2012; 127(1):34-42. PubMed ID: 22005133
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic abnormalities in 532 patients with myeloid leukemias and myelodyplastic syndrome. The Czechoslovak MDS Cooperative Group.
Michalová K; Musilová J; Zemanová Z
Czech Med; 1990; 13(4):133-44. PubMed ID: 2081440
[TBL] [Abstract][Full Text] [Related]
19. [Karyotypic analysis and prognosis for 41 patients with chronic myelomonocytic leukemia].
Lu Y; Yu MX; Mu QT; Wang Q; Chen ZM; Lou JY; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):134-7. PubMed ID: 23568720
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera.
Tang G; Hidalgo Lopez JE; Wang SA; Hu S; Ma J; Pierce S; Zuo W; Carballo-Zarate AA; Yin CC; Tang Z; Li S; Medeiros LJ; Verstovsek S; Bueso-Ramos CE
Haematologica; 2017 Sep; 102(9):1511-1518. PubMed ID: 28473622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
